Uncategorized
STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 1, 2022. Second Quarter 2022 Overview Record Net Sales of $81.1 Million Up 30% and Constant Currency Net Sales of $84.2 Million Up 35% from the Prior Year Quarter Record ICL Sales of $77.9 Million Up 32% and Constant Currency ICL Sales of $80